Variations in cell signaling pathways for different vasoconstrictor agonists in renal circulation of the rat

Kidney International

Volumn 63, Issue 6, 2003, Pages 2178-2186

  Bauer, Johannes ^a   Parekh, Niranjan ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Angiotensin II; Arginine vasopressin; L type Ca2+ channels; Norepinephrine; Protein kinase C; Renal blood flow; Rho associated kinase; U 46619

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANGIOTENSIN; ARGIPRESSIN; CALCIUM CHANNEL L TYPE; CALCIUM ION; FASUDIL; INOSITOL 1,4,5 TRISPHOSPHATE; NIFEDIPINE; NORADRENALIN; PROTEIN KINASE C; RHO KINASE; STAUROSPORINE; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CALCIUM MOBILIZATION; CELL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; INHIBITION KINETICS; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; PHOSPHATE TRANSPORT; PRIORITY JOURNAL; RAT; RENAL ARTERY; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 0037513330     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00021.x     Document Type: Article

References (38)

1. SOMLYO AP, SOMLYO AV: Signal transduction and regulation in smooth muscle. Nature 372:231-236, 1994
2. HOROWITZ A, MENICE CB, LAPORTE R, MORGAN KG: Mechanisms of smooth muscle contraction. Physiol Rev 76:967-1003, 1996
3. GOHLA A, SCHULTZ G, OFFERMANNS S: Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circ Res 87:221-277, 2000
4. NODA M, YASUDA-FUKAZAWA C, MORIISHI K, et al: Involvement of rho in GTPγS-induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: Inhibition of phosphatase activity. FEBS Lett 367:246-250, 1995
5. KIMURA K, ITO M: AMANO M, et al: Regulation of myosin phosphatase by rho and rho-associated kinase (rho-kinase). Science 273:245-248, 1996
6. SOMLYO AP, WU X, WALKER LA, SOMLYO AV: Pharmacomechanical coupling: The role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Biochem Pharmacol 134:201-234, 1999
7. SOMLYO AP, SOMLYO AV: Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J. Physiol 522:177-185, 2000
8. PFITZER G: Invited review: Regulation of myosin phosphorylation in smooth muscle. J Appl Physiol 91:497-503, 2001
9. PAREKH N: A novel method for infusing drugs continuously into the renal artery of rats. Am J Physiol 268:F967-F971, 1995
10. CHIOU CY, MALAGODI MH: Studies on the mechanism of action of a new Ca-2+ antagonist, 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride in smooth and skeletal muscles. Br J Pharmacol 53:279-285, 1975
11. VAN DER LEE R, PFAFFENDORF M, KOOPMANS RP, et al: Comparison of the time courses and potencies of the vasodilator effects of nifedipine and felodipine in the human forearm. Blood Press 10:217-222, 2001
12. WILKINSON SE, PARKER PJ, NIXON JS: Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 294:335-337, 1993
13. DAVIES SP, REDDY H, CAIVANO M, COHEN P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105, 2000
14. UEHATA M, ISHIZAKI T, SATOH H, et al: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389:990-994, 1997
15. 2-induced mesenteric vasoconstriction in rats mediated by separate cell signaling pathways. Am J Physiol 277:H1-H7, 1999
16. 2+-free media are mediated by different signal transduction pathways in rat aorta. BrJ Pharmacol 110:875-881, 1993
17. SWARD K, DREJA K, SUSNJAR M, et al: Inhibition of Rho-associated kinase blocks agonist-induced Ca2+ sensitization of myosin phosphorylation and force in guinea-pig ileum. J Physiol 522:33-49, 2000
18. COOPER CL, MALIK KU: Mechanism of action of vasopressin on prostaglandin synthesis and vascular function in the isolated rat kidney: Effect of calcium antagonists and calmodulin inhibitors. J Pharmacol Exp Ther 229:139-147, 1984
19. FENG JJ, ARENDSHORST WJ: Calcium signaling mechanisms in renal vascular responses to vasopressin in genetic hypertension. Hypertension 30:1223-1231, 1997
20. RUAN X, ARENDSHORST WJ: Calcium entry and mobilization signaling pathways in ANG II-induced renal vasoconstriction in vivo. Am J Physiol 270:F398-F405, 1996
21. RUAN X, ARENDSHORST WJ: Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats. Am J Physiol 270:F945-F952, 1996
22. SALOMONSSON M, ARENDSHORST WJ: Calcium recruitment in renal vasculature: NE effects on blood flow and cytosolic calcium concentration. Am J Physiol 276:F700-F710, 1999
23. SCHOLZ H, KURTZ A: Role of protein kinase C in renal vasoconstriction caused by angiotensin II. Am J Physiol 259:C421-C426, 1990
24. IVERSEN BM, ARENDSHORST WJ: ANG II and vasopressin stimulate calcium entry in dispersed smooth muscle cells of preglomerular arterioles. Am J Physiol 274:F498-508, 1998
25. LOUTZENHISER R, EPSTEIN M, HORTON C, SONKE P: Reversal of renal and smooth muscle actions of the thromboxane mimetic U-44069 by diltiazem. Am J Physiol 250:F619-F626, 1986
26. HAYASHI K, LOUTZENHISER R, EPSTEIN M: Direct evidence that thromboxane mimetic U44069 preferentially constricts the afferent arteriole. J Am Soc Nephrol 8:25-31, 1997
27. REMUZZI G, FITZGERALD GA, PATRONO C: Thromboxane synthesis and action within the kidney. Kidney Int 41:1483-1493, 1992
28. KAYE AD, NOSSAMAN BD, IBRAHIM IN, KADOWlTZ PJ: Influence of PLC and MLCK inhibitors and the role of L-calcium channels in the cat pulmonary vascular bed. Am J Physiol 269:L507-L513, 1995
29. KAYE AD, NOSSAMAN BD, IBRAHIM IN, et al: Influence of protein kinase C inhibitors on vasoconstrictor responses in the pulmonary vascular bed of cat and rat. Am J Physiol 268:L532-L538, 1995
30. ++dependent protein kinase. Biochem Biophys Res Commun 135:397-402, 1986
31. ETO M, KITAZAWA T, YAZAWA M, et al: Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C α and δ isoforms. J Biol Chem 276:29072-29078, 2001
32. STEINHAUSEN M, ENDLICH K, WIEGMAN DL: Glomerular blood flow. Kidney Int 38:769-784, 1990
33. MATROUGUI K, TANKO LB, LOUFRANI L, et al: Involvement of Rho-kinase and the actin filament network in angiotensin II-induced contraction and extracellular signal-regulated kinase activity in intact rat mesenteric resistance arteries. Arterioscler Thromb Vasc Biol 21:1288-1293, 2001
34. CHRISSOBOLIS S, SOBEY CG: Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: Comparison with protein kinase. Circ Res 88:774-779, 2001
35. SATO M, TANI E, FUJIKAWA H, KAIBUCHI K: Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 87:195-200, 2000
36. KANDABASHI T, SHIMOKAWA H, MIYATA K, et al: Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation 101:1319-1323, 2000
37. CHITALEY K, WINGARD CJ, CLINTON WEBB R, et al: Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med 7:119-122, 2001
38. SAKURADA S, OKAMOTO H, TAKUWA N, et al: Rho activation in excitatory agonist-stimulated vascular smooth muscle. Am J Physiol 281:C571-C578, 2001